Our range of products include nintedoc 100 nintedanib soft gelatin capsule ofev & vargatef, nindanib 150 nintedanib soft gelatin capsule ofev & vargatef, nindanib 100 nintedanib soft gelatin capsule ofev & vargatef, nintib 150 nintedanib soft gelatin capsule ofev & vargatef, nintib 100 nintedanib soft gelatin capsule ofev & vargatef and vivitra 375mg trastuzumab herceptin injection.
₹ 2500 / Box Get Latest Price
| Strength | 100 mg |
| Brand | Nintedoc |
| Capsules per Pack | 10 Capsules |
| Usage | Cancer Care, Lung Cancer |
| Form | Capsule |
| Pack Type | Blister |
| Manufacturer | Dr Morepen |
Nintedoc 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®
Nintedoc 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that inhibits multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby slowing disease progression in fibrotic lung disorders and suppressing tumor angiogenesis. Nintedoc 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) under specific therapeutic protocols.
High-ranking search keywords include: Nintedanib 100mg capsule, Nintedoc 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD medication, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nintedoc 100 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.
₹ 1214.06 / Box Get Latest Price
| Strength | 150 mg |
| Brand | Nindanib |
| Capsules per Pack | 10 Capsules |
| Usage | Cancer Care, Lung Cancer |
| Form | Capsule |
| Pack Type | Blister |
| Marketer | Glenmark Pharmaceuticals Ltd |
Nindanib 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®
Nindanib 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nindanib 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nindanib 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in defined clinical settings.
High-ranking search keywords include: Nintedanib 150mg capsule, Nindanib 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nindanib 150 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with full regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital supply chains, and international pharmaceutical distributors.
₹ 923.9 / Box Get Latest Price
| Strength | 100 mg |
| Brand | Nindanib |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Blister |
| Marketer | Glenmark Pharmaceuticals Ltd |
Nindanib 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®
Nindanib 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nindanib 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that inhibits multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby slowing disease progression in fibrotic lung disorders and suppressing tumor angiogenesis. Nindanib 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) under defined therapeutic protocols.
High-ranking search keywords include: Nintedanib 100mg capsule, Nindanib 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD medication, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nindanib 100 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.
₹ 1060.64 / Box Get Latest Price
| Strength | 150 mg |
| Brand | Nintib |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Blister |
| Marketer | Cipla Ltd |
Nintib 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®
Nintib 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintib 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nintib 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in specific clinical settings.
High-ranking search keywords include: Nintedanib 150mg capsule, Nintib 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nintib 150 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with full regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.
₹ 860.99 / Box Get Latest Price
| Strength | 100 mg |
| Brand | Nintib |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Blister |
| Marketer | Cipla Ltd |
Nintib 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®
Nintib 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintib 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nintib 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in specific clinical settings.
High-ranking search keywords include: Nintedanib 100mg capsule, Nintib 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nintib 100 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.
₹ 13026.5 / Piece Get Latest Price
| Strength | 375 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Standard Trastuzumab |
| Brand | Vivitra |
| Treatment | Breast Cancer |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Dosage Form | Injection |
| Administration Route | IV Infusion |
| Composition | Trastuzumab |
Vivitra 375mg Injection
Composition: Trastuzumab Injection 375mg
International Trade Name: Herceptin®
Vivitra 375 is a high-quality Trastuzumab 375mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Vivitra 375 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.
Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Vivitra 375 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered alone or in combination with chemotherapy according to established treatment protocols.
High-ranking search keywords include: Trastuzumab 375mg injection, Vivitra 375 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.
Vivitra 375 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.
₹ 22080.10 / Piece Get Latest Price
| Strength | 150 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Standard Trastuzumab |
| Brand | Canmab |
| Treatment | Breast Cancer |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Dosage Form | Injection |
| Administration Route | IV Infusion |
| Composition | Trastuzumab |
Canmab 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®
Canmab 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Canmab 150 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.
Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Canmab 150 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered alone or in combination with chemotherapy as per established treatment protocols.
High-ranking search keywords include: Trastuzumab 150mg injection, Canmab 150 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.
Canmab 150 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.
₹ 40688 / Vial Get Latest Price
| Strength | 500 mg |
| Dosage Form | Concentrate |
| Brand | Reditux |
| Storage Temperature | 2-8 degree c |
| Manufacturer | Dr. Reddy's Laboratories |
| Shelf Life | 36 months |
| Packaging Type | Vial |
| Treatment | Non-Hodgkin Lymphoma |
| Dose | 500 mg per m2 |
| Administration Route | Intravenous Infusion |
| Composition | Rituximab |
Reditux 500mg Injection
Composition: Rituximab Injection 500mg
International Trade Name: Rituxan®
Reditux 500 is a high-quality Rituximab 500mg Injection, a biosimilar of the internationally renowned anti-CD20 monoclonal antibody marketed under the brand name Rituxan®. Manufactured in WHO-GMP certified facilities, Reditux Injection is supplied by trusted pharmaceutical exporters from India to support global oncology, hematology, and immunology treatment programs.
Rituximab is a chimeric monoclonal antibody that selectively targets the CD20 antigen expressed on B-lymphocytes, leading to B-cell lysis through complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and induction of apoptosis. Reditux 500mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and is also widely used in autoimmune disorders such as rheumatoid arthritis in combination therapy.
High-ranking search keywords include: Rituximab 500mg injection, Reditux 500 injection, Rituxan biosimilar, rituximab price, non-Hodgkin lymphoma treatment, CD20 monoclonal antibody, oncology biologics exporter India, and biosimilar manufacturer India.
Reditux 500 Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology and hematology centers, infusion clinics, government supply programs, and international pharmaceutical distributors.
₹ 53430 / Piece Get Latest Price
| Strength | 160 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Trastuzumab Emtansine |
| Brand | Ujvira |
| Treatment | Breast Cancer |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Dosage Form | Lyophilized Powder for Injection |
| Administration Route | Intravenous |
| Composition | Trastuzumab |
Ujvira 160mg Injection
Composition: Trastuzumab Emtansine Injection 160mg
International Trade Name: Kadcyla®
Ujvira 160 is a high-quality Trastuzumab Emtansine 160mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted antibody–drug conjugate (ADC) marketed under the brand name Kadcyla®. Manufactured in WHO-GMP certified facilities, Ujvira Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in HER2-positive breast cancer.
Trastuzumab emtansine (T-DM1) combines the HER2-targeting monoclonal antibody trastuzumab with the potent cytotoxic agent DM1 (emtansine), enabling targeted delivery of chemotherapy directly to HER2-overexpressing cancer cells. Ujvira 160mg Injection is primarily indicated for the treatment of HER2-positive metastatic or early breast cancer, especially in patients previously treated with trastuzumab and taxane-based therapy.
High-ranking search keywords include: Trastuzumab emtansine 160mg injection, Ujvira 160 injection, Kadcyla biosimilar, T-DM1 price, HER2-positive breast cancer treatment, ADC oncology injection, biologics exporter India, and anticancer monoclonal antibody manufacturer India.
Ujvira 160 Trastuzumab Emtansine Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.
₹ 23127.19 / Piece Get Latest Price
| Strength | 150 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Standard Trastuzumab |
| Brand | Vivitra |
| Treatment | Breast Cancer |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Box |
| Shelf Life | 36 months |
| Dosage Form | Lyophilized Powder for Injection |
| Administration Route | Intravenous |
| Composition | Trastuzumab |
Vivitra 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®
Vivitra 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities, Vivitra Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs, particularly in HER2-positive cancers.
Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2/neu receptor, inhibiting tumor cell proliferation and mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Vivitra 150mg Injection is primarily indicated for the treatment of HER2-positive breast cancer (early-stage and metastatic) and HER2-positive gastric or gastroesophageal junction adenocarcinoma, either as monotherapy or in combination chemotherapy regimens.
High-ranking search keywords include: Trastuzumab 150mg injection, Vivitra 150 injection, Herceptin biosimilar, trastuzumab price, HER2-positive breast cancer treatment, monoclonal antibody oncology injection, biologics exporter India, and biosimilar manufacturer India.
Vivitra 150 Trastuzumab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.
₹ 40690.99 / Vial Get Latest Price
| Strength | 500 mg |
| Dosage Form | Solution for Infusion |
| Brand | Mabtas |
| Storage Temperature | 2-8 degree c |
| Manufacturer | Intas Pharmaceuticals |
| Shelf Life | 36 months |
| Packaging Type | Vial |
| Treatment | Non-Hodgkin Lymphoma |
| Administration Route | Intravenous Infusion |
| Composition | Rituximab |
Mabtas RA 500mg Injection
Composition: Rituximab Injection 500mg
International Trade Name: Rituxan®
Mabtas RA 500 is a high-quality Rituximab 500mg Injection, a biosimilar equivalent of the internationally recognized anti-CD20 monoclonal antibody marketed under the brand name Rituxan®. Manufactured in WHO-GMP certified facilities, Mabtas RA Injection is supplied by trusted pharmaceutical exporters from India to support global oncology, hematology, and autoimmune disease treatment programs.
Rituximab is a chimeric monoclonal antibody that selectively targets the CD20 antigen on B-lymphocytes, leading to B-cell depletion through complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and induction of apoptosis. Mabtas RA 500mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and rheumatoid arthritis (RA) in combination with methotrexate, as well as other autoimmune indications.
High-ranking search keywords include: Rituximab 500mg injection, Mabtas RA 500 injection, Rituxan biosimilar, rituximab price, CD20 monoclonal antibody therapy, NHL and RA treatment, biologics exporter India, and biosimilar manufacturer India.
Mabtas RA 500 Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, rheumatology clinics, hospitals, government supply programs, and international pharmaceutical distributors.
₹ 14053.13 / Piece Get Latest Price
| Strength | 375 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Standard Trastuzumab |
| Brand | Eleftha |
| Treatment | Breast Cancer |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Dosage Form | Injection |
| Administration Route | Intravenous |
| Composition | Trastuzumab |
Eleftha 375mg Injection
Composition: Trastuzumab Injection 375mg
International Trade Name: Herceptin®
Eleftha 375 is a high-quality Trastuzumab 375mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities, Eleftha Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs, particularly in HER2-positive cancers.
Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2/neu receptor, inhibiting tumor cell proliferation and mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Eleftha 375mg Injection is primarily indicated for the treatment of HER2-positive breast cancer (early-stage and metastatic) and HER2-positive gastric or gastroesophageal junction adenocarcinoma, either as monotherapy or in combination chemotherapy regimens.
High-ranking search keywords include: Trastuzumab 375mg injection, Eleftha 375 injection, Herceptin biosimilar, trastuzumab price, HER2-positive breast cancer treatment, monoclonal antibody oncology injection, biologics exporter India, and biosimilar manufacturer India.
Eleftha 375 Trastuzumab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.
₹ 1692.19 / Box Get Latest Price
| Strength | 50 mg |
| Brand | Revolade |
| Pack Size | 7 Tablets |
| Composition | Eltrombopag Olamine |
| Form | Tablet |
| Shelf Life | 36 Months |
| Manufacturer | ZYDUS CADILA |
Elromo 50 Tablet
Composition: Eltrombopag Tablets 50mg
International Trade Name: Promacta, Revolade
Elromo 50 is a premium Eltrombopag 50mg tablet supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Eltrombopag 50mg, widely recognized under the international brands Promacta and Revolade, used in the treatment of thrombocytopenia and other platelet disorders.
High-ranking search terms include Eltrombopag 50mg tablet, Elromo 50 tablet, Promacta generic tablets, Revolade equivalent tablets, Eltrombopag exporter India, Eltrombopag bulk supplier, and Eltrombopag 50mg manufacturer India.
Manufactured under strict GMP standards, Elromo 50 ensures precise dosage, consistent quality, and export-grade packaging, making it suitable for global pharmaceutical distribution.
₹ 29700 / Bottle Get Latest Price
| Strength | 250 mg |
| Brand | Samtica |
| Tablets per Pack | 120 Tablets |
| Pack Type | Bottle |
| Usage | Cancer Care, Prostate Cancer |
| Form | Tablet |
| Release Type | Uncoated |
Samtica 250 mg contains Abiraterone Acetate 250 mg, a well-established medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer, as prescribed by an oncologist.
Abiraterone Acetate works by blocking androgen production, which helps slow the growth and spread of prostate cancer cells. Internationally, Abiraterone is widely known under the reference brand Zytiga, making Samtica a trusted therapeutic option in oncology care.
Key BenefitsContains Abiraterone Acetate 250 mg
Used in advanced prostate cancer treatment
Helps reduce androgen levels that fuel cancer growth
Widely prescribed and clinically proven
Oral tablet for convenient administration
Brand Name: Samtica
Generic Name: Abiraterone Acetate
Strength: 250 mg
Dosage Form: Tablets
Reference Brand: Zytiga
Indication: Prostate Cancer (as prescribed)
Samtica 250 mg, Abiraterone Acetate 250 mg tablets, Zytiga alternative, buy Abiraterone Acetate, prostate cancer tablets, Abiraterone 250 mg, oncology medicines Abiraterone.
Why Choose This Product?Manufactured by licensed pharmaceutical companies
Quality-assured and export-ready
Cost-effective alternative to branded Zytiga
Trusted by healthcare providers globally
Q1. What is Samtica 250 mg used for?
It is used for the treatment of advanced prostate cancer, under medical supervision.
Q2. Is Samtica the same as Zytiga?
Samtica contains the same active ingredient, Abiraterone Acetate, as Zytiga.
Q3. How should Abiraterone be taken?
It is usually taken on an empty stomach, along with prednisone, as directed by a doctor.
Q4. Is this product genuine?
Yes, it is sourced from licensed manufacturers with proper quality documentation.
Q5. Do you supply internationally?
Yes, international supply is available, subject to local regulations.
₹ 12436.88 / Piece Get Latest Price
| Route Of Administration | Subcutaneous |
| Brand | Azacytin |
| Strength | 200 mg |
| Treatment | Myelodysplastic Syndrome |
| Form | Tablet |
| Dose Type | Oral |
| Physical Form | Solution |
| Indication | MDS, AML, CMML |
| Packaging Size | 14 Tablets |
| Storage | Below 30 degree c |
| Pack Type | Strip |
| Shelf Life | 24 Months |
| Salt Composition | Azacitidine |
| manufacturer | Dr Reddy's Laboratories Ltd |
Product Title: Azacytin 200mg | Azacitidine for Injection | Professional Strength Generic Vidaza
Description:
Elevate your clinical outcomes with Azacytin 200mg, a high-strength Azacitidine for Injection formulation. Designed for precision dosing in oncology settings, Azacytin 200mg serves as a reliable, cost-effective alternative to Vidaza. This antimetabolite is specifically engineered for the treatment of Myelodysplastic Syndromes (MDS) subtypes and Acute Myeloid Leukemia (AML) where higher concentration per vial is required.
By inhibiting DNA methyltransferase, Azacytin restores normal growth to bone marrow cells. This 200mg lyophilized powder ensures streamlined preparation for healthcare providers handling high-volume treatment cycles.
Product Specifications:
Strength: 200mg Azacitidine per vial.
Usage: Subcutaneous (SC) or Intravenous (IV) administration after reconstitution.
Indication: FIGO/WHO classified Myelodysplastic Syndromes and AML.
Storage: Controlled room temperature ($25^\circ\text{C}$); excursions permitted between $15^\circ\text{C}$ and $30^\circ\text{C}$.
Secure Azacytin 200mg (Azacitidine for Injection). The high-potency generic for Vidaza used in MDS & AML therapy. Quality-assured oncology medication.
Primary Keywords: Azacytin 200mg, Azacitidine for Injection 200mg, Azacitidine 200mg Vial, High-dose Azacitidine.
Secondary Keywords: Oncology injections, Vidaza 200mg alternative, MDS chemotherapy 200mg, Azacitidine lyophilized powder.
Long-tail Keywords: Buy Azacytin 200mg online, Azacitidine 200mg price for injection, Azacytin 200mg manufacturer specifications.
₹ 1000 / Strip Get Latest Price
| Strength | 400 mg |
| Brand | Glivec, Gleevec |
| Composition | Imatinib Mesylate |
| Manufacturer | Novartis |
| Usage | CML, DFSP, Other Leukemia, ALL Ph+, GIST |
| Tablets per Pack | 10 Tablets |
| Pack Type | Strip |
| Form | Tablet |
Glivec 400mg Imatinib Mesylate Tablets are widely used in the treatment of certain types of cancer, especially blood cancers and gastrointestinal tumors. This medicine contains Imatinib Mesylate 400mg, a targeted therapy that works by blocking abnormal proteins responsible for the growth of cancer cells.
Glivec is commonly prescribed for conditions such as Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). It helps slow or stop the spread of cancer cells and supports long-term disease management when taken under medical supervision.
Key UsesTreatment of Chronic Myeloid Leukemia (CML)
Treatment of Gastrointestinal Stromal Tumors (GIST)
Certain types of blood cancers
Targeted cancer therapy
Brand Name: Glivec 400mg
Generic Name: Imatinib Mesylate
Strength: 400mg
Dosage Form: Tablets
Category: Anti-cancer / Oncology Medicine
Targeted cancer treatment
Helps slow cancer cell growth
Widely used oncology therapy
Trusted treatment for leukemia and GIST
₹ 3000 / Bottle Get Latest Price
| Strength | 500 mg |
| Brand | Abirakast |
| Tablets per Pack | 60 Tablets |
| Usage | Cancer Care, Prostate Cancer |
| Pack Type | Bottle |
| Shelf Life | 36 Months |
| Composition | Abiraterone Acetate 500 mg |
| Form | Tablet |
| Country of Origin | India |
Abirakast Abiraterone Acetate 500 mg Tablets are a highly effective and widely used medication for the treatment of advanced prostate cancer. Formulated with Abiraterone Acetate, this therapy works by reducing androgen production in the body, which helps slow down the growth and spread of cancer cells.
As a registered pharmacist from India, I ensure the supply of genuine Abirakast 500 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Abirakast 500 mg (Abiraterone Acetate)?Abirakast 500 mg contains Abiraterone Acetate 500 mg, a potent anti-cancer medication used for:
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
It is commonly prescribed along with corticosteroids such as prednisone to enhance treatment effectiveness.
Abiraterone Acetate 500 mg UsesKey uses of Abiraterone Acetate 500 mg tablets include:
Reducing androgen (testosterone) production
Slowing cancer progression
Supporting long-term disease management
Improving overall survival outcomes
Abiraterone Acetate belongs to a class of drugs known as androgen biosynthesis inhibitors. It works by:
Blocking the CYP17 enzyme responsible for androgen production
Reducing hormone levels that fuel prostate cancer
Helping control tumor growth and spread
Take Abirakast 500 mg tablets exactly as prescribed by a healthcare professional
Usually taken once daily on an empty stomach
Swallow whole with water; do not crush or chew
Abiraterone is available in different strengths for flexible treatment:
Abirakast 250 mg tablets
Abirakast 500 mg tablets
Packaging options may vary depending on treatment requirements and supply.
Why Choose Us?As a registered pharmacist and pharmaceutical exporter from India, we provide:
Genuine and quality-assured oncology medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable international shipping
Complete export documentation
Professional customer support
Abirakast Abiraterone Acetate 500 mg Tablets are a trusted and effective solution for managing advanced prostate cancer. With assured quality, expert handling, and reliable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 3000 / Box Get Latest Price
| Strength | 50 mg |
| Brand | Eltrombo |
| Pack Size | 28 Tablets |
| Manufacturer | Aprazer Healthcare |
| Form | Tablet |
| Composition | Eltrombopag Olamine |
| Shelf Life | 36 Months |
| Prescription Type | Prescription |
| Indication | HCV Thrombocytopenia, Aplastic Anaemia, ITP |
Eltrombo 50 mg Eltrombopag Olamine Tablets 50 mg is a clinically trusted medication used for the treatment of low platelet count (thrombocytopenia). It contains Eltrombopag Olamine, a thrombopoietin receptor agonist that helps stimulate platelet production and maintain healthy platelet levels.
As a registered pharmacist from India, I ensure the supply of genuine Eltrombo 50 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a reliable choice for hospitals, distributors, and healthcare providers worldwide.
What is Eltrombo 50 mg (Eltrombopag Olamine)?Eltrombo 50 mg contains Eltrombopag Olamine 50 mg, which is commonly prescribed for:
Chronic Immune Thrombocytopenia (ITP)
Aplastic Anemia
Thrombocytopenia associated with chronic hepatitis C
It is used to increase platelet levels and reduce the risk of bleeding complications.
Eltrombopag 50 mg UsesKey uses of Eltrombopag 50 mg tablets include:
Stimulating platelet production in the bone marrow
Reducing the risk of bleeding
Supporting treatment of chronic blood disorders
Maintaining stable platelet counts
Eltrombopag Olamine works by:
Activating thrombopoietin receptors
Increasing platelet production
Helping restore normal platelet levels
Take Eltrombo 50 mg tablets exactly as prescribed by a healthcare professional
Usually taken once daily on an empty stomach
Avoid taking with dairy products or mineral supplements close to dosing
Eltrombopag tablets are available in multiple strengths:
25 mg
50 mg
75 mg
As a registered pharmacist and pharmaceutical exporter from India, we offer:
Genuine and quality-assured medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable global shipping
Complete export documentation
Professional customer support
Eltrombo 50 mg (Eltrombopag Olamine Tablets 50 mg) is a trusted and effective solution for managing low platelet counts and related conditions. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 500 / Strip Get Latest Price
| Strength | 100 mg |
| Brand | Imatikast |
| Composition | Imatinib Mesylate |
| Manufacturer | Aprazer |
| Usage | GIST, CML, Other Leukemia, ALL Ph+, DFSP |
| Tablets per Pack | 10 Tablets |
| Pack Type | Strip |
| Form | Tablet |
Imatikast 100 mg Imatinib Tablets IP 100 mg is a highly effective targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML) and other cancers. It contains Imatinib, a tyrosine kinase inhibitor that helps block abnormal cancer cell growth and control disease progression.
As a registered pharmacist from India, I ensure the supply of genuine Imatikast 100 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Imatikast 100 mg (Imatinib)?Imatikast 100 mg contains Imatinib 100 mg, which is commonly prescribed for:
Chronic Myeloid Leukemia (CML)
Gastrointestinal Stromal Tumors (GIST)
Acute Lymphoblastic Leukemia (Ph+ ALL)
It is a targeted therapy designed to control the growth of cancer cells effectively.
Imatinib 100 mg UsesKey uses of Imatinib 100 mg tablets include:
Blocking cancer cell growth
Reducing abnormal white blood cell production
Supporting long-term disease control
Improving treatment outcomes in leukemia and tumors
Imatinib belongs to the class of tyrosine kinase inhibitors (TKIs). It works by:
Inhibiting the BCR-ABL protein responsible for leukemia
Blocking signals that promote cancer cell growth
Slowing disease progression
Take Imatikast 100 mg tablets exactly as prescribed by a healthcare professional
Usually taken once or twice daily with food and water
Swallow whole; do not crush or chew
Imatinib tablets are available in multiple strengths:
100 mg
200 mg
400 mg
As a registered pharmacist and pharmaceutical exporter from India, we provide:
Genuine and quality-assured oncology medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable international shipping
Complete export documentation
Professional customer support
Imatikast 100 mg (Imatinib Tablets IP 100 mg) is a trusted and effective targeted therapy for leukemia and related cancers. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 600 / Strip Get Latest Price
| Strength | 400 mg |
| Brand | Imatikast |
| Composition | Imatinib Mesylate |
| Manufacturer | Aprazer Healthcare |
| Usage | ALL Ph+, DFSP, Other Leukemia, CML, GIST |
| Tablets per Pack | 10 Tablets |
| Pack Type | Strip |
| Form | Tablet |
Imatikast 400 mg Imatinib Tablets IP 400 mg is a highly effective targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML) and other malignancies. It contains Imatinib, a tyrosine kinase inhibitor that helps block abnormal cancer cell growth and control disease progression.
As a registered pharmacist from India, I ensure the supply of genuine Imatikast 400 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Imatikast 400 mg (Imatinib)?Imatikast 400 mg contains Imatinib 400 mg, which is commonly prescribed for:
Chronic Myeloid Leukemia (CML)
Gastrointestinal Stromal Tumors (GIST)
Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
It is a targeted therapy designed to effectively manage cancer progression.
Imatinib 400 mg UsesKey uses of Imatinib 400 mg tablets include:
Blocking cancer cell growth
Reducing abnormal white blood cell production
Supporting long-term disease control
Improving treatment outcomes in leukemia and tumors
Imatinib belongs to the class of tyrosine kinase inhibitors (TKIs). It works by:
Inhibiting the BCR-ABL protein responsible for leukemia
Blocking signals that promote cancer cell growth
Slowing disease progression
Take Imatikast 400 mg tablets exactly as prescribed by a healthcare professional
Usually taken once daily with food and water
Swallow whole; do not crush or chew
Imatinib tablets are available in multiple strengths:
100 mg
200 mg
400 mg
As a registered pharmacist and pharmaceutical exporter from India, we provide:
Genuine and quality-assured oncology medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable international shipping
Complete export documentation
Professional customer support
Imatikast 400 mg (Imatinib Tablets IP 400 mg) is a trusted and effective targeted therapy for leukemia and related cancers. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 15000 / Box Get Latest Price
| Drug Name | Erdafitinib |
| Composition | Erdafitinib |
| Strength | 4 mg |
| Pack Size | 28 tablets |
| Brand Name | Erdanat |
| Brand | Natco |
| Packaging Size | 28 Tablets |
| Form | Tablet |
| Manufacturer | Natco Pharma |
| Packaging Type | Bottle |
| Treatment | cGVHD, Blood Cancer, MZL, WM, Mantle-cell lymphoma, Lung Cancer, CLL / SLL |
| Country of Origin | India |
Erdanat 4 mg Erdafitinib 4 mg Tablet is a highly effective targeted anti-cancer medication used in the treatment of advanced or metastatic urothelial carcinoma (bladder cancer). It contains Erdafitinib, a fibroblast growth factor receptor (FGFR) inhibitor that works by blocking cancer cell growth at the molecular level.
As a registered pharmacist from India, I ensure the supply of genuine Erdanat 4 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Erdanat 4 mg (Erdafitinib)?Erdanat 4 mg contains Erdafitinib 4 mg, which is primarily prescribed for:
It is a precision-targeted therapy designed for personalized cancer treatment.
Erdafitinib 4 mg UsesKey uses of Erdafitinib 4 mg tablets include:
Erdafitinib belongs to the class of FGFR inhibitors. It works by:
Erdafitinib tablets are available in different strengths:
As a registered pharmacist and pharmaceutical exporter from India, we provide:
Erdanat 4 mg (Erdafitinib 4 mg Tablet) is a trusted and effective targeted therapy for advanced bladder cancer. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.
₹ 365 / Box Get Latest Price
| Strength | 5 mg |
| Brand | Apiedge |
| Pack Size | 10 tablets |
| Composition | Apixaban 5 mg |
| Packaging Type | Blister |
| Country of Origin | India |
| Manufacturer | Dr Morepen |
Apiedge 5mg Tablet
Composition: Apixaban Tablets 5mg
International Trade Name: Eliquis®
Apiedge 5 is a high-quality Apixaban 5mg Tablet, a generic equivalent of the internationally recognized direct oral anticoagulant (DOAC) Eliquis®. Manufactured in WHO-GMP certified facilities, Apiedge 5 Tablets are supplied by trusted pharmaceutical exporters from India to support global cardiovascular care and thrombosis management programs.
Apixaban is a selective Factor Xa inhibitor that prevents thrombin generation and clot formation without the need for routine coagulation monitoring. Apiedge 5 Tablets are primarily indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), and post-operative thromboprophylaxis following hip or knee replacement surgery.
High-ranking search keywords include: Apixaban 5mg tablet, Apiedge 5 tablet, Eliquis generic tablet, apixaban price, factor Xa inhibitor, anticoagulant tablet, apixaban exporter India, cardiovascular drug manufacturer India, and DOAC tablet supplier.
Apiedge 5 Apixaban Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospital cardiology departments, internal medicine clinics, specialty pharmacies, and international pharmaceutical distributors.
₹ 1214.06 / Box Get Latest Price
| Strength | 150 mg |
| Brand | Nintedoc |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Blister |
| Manufacturer | Dr Morepen |
Nintedoc 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®
Nintedoc 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Nintedoc 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.
High-ranking search keywords include: Nintedanib 150mg capsule, Nintedoc 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nintedoc 150 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.
₹ 3000 / Box Get Latest Price
| Strength | 150 mg |
| Brand | Nintedoc |
| Capsules per Pack | 10 Capsules |
| Usage | Cancer Care, ILD, Lung Cancer |
| Form | Capsule |
| Pack Type | Blister |
| Manufacturer | Dr Morepen |
Nintedoc 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®
Nintedoc 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Nintedoc 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.
High-ranking search keywords include: Nintedanib 150mg capsule, Nintedoc 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Nintedoc 150 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.
₹ 22000 / Box Get Latest Price
| Composition | Enzalutamide |
| Strength | 80 mg |
| Brand Name | Azel |
| Packaging Size | 56 Capsule |
| Form | Capsule |
| Manufacturer | Dr. Reddy's Labs |
| Packaging Type | Blister Pack |
| Treatment | CLL / SLL, MZL, cGVHD, WM, Mantle-cell lymphoma, Blood Cancer, Lung Cancer |
| Usage / Application | Personal Use |
| Country of Origin | India |
₹ 22687 / Piece Get Latest Price
| Strength | 150 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Standard Trastuzumab |
| Brand | Trasturel |
| Treatment | Breast Cancer |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Dosage Form | Injection |
| Administration Route | IV Infusion |
| Composition | Trastuzumab |
Trasturel 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®
Trasturel 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Trasturel 150 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.
Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Trasturel 150 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered as monotherapy or in combination with chemotherapy according to established treatment protocols.
High-ranking search keywords include: Trastuzumab 150mg injection, Trasturel 150 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.
Trasturel 150 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.
₹ 300 / Box Get Latest Price
| Strength | 250 mg |
| Dose/Strength | 250 mg |
| Brand | Geftib |
| Packaging Size | 1*10 Tablets |
| Composition | Gefitinib |
| Dosage Form | Tablet |
| Prescription | Prescription |
| Usage/Application | Personal |
| Manufacturer | Panocea Biotech |
| Shelf Life | 36 month's |
| Packaging Type | Stripe |
Gefi Trust Tablets (Gefitinib 250 mg) by Shivanta Impex is a premium-quality pharmaceutical formulation supplied for international markets. Gefi Trust contains Gefitinib 250 mg Tablets IP, globally recognized under the trade name Iressa. Manufactured under strict quality standards, this product ensures accurate formulation, consistent potency, secure packaging, and export-grade stability. Shivanta Impex is a trusted Indian exporter of oncology pharmaceutical products.
Gefitinib 250 mg Tablet, Gefi Trust Tablet, Iressa generic, Gefitinib exporter India, Gefitinib supplier, Gefitinib manufacturer, Gefitinib bulk export, Gefitinib international supply
₹ 1000 / Bottle Get Latest Price
| Strength | 40 mg |
| Brand | Cabozer |
| Tablets per Pack | 30 Tablets |
| Usage | Renal Cancer, Cancer Care, Thyroid Cancer, Liver Cancer |
| Form | Tablet |
| Pack Type | Bottle |
Cabozer 40 mg Cabozantinib Tablets 40 mg is a highly effective targeted anti-cancer medication used in the treatment of advanced cancers, including kidney, liver, and thyroid cancers. It contains Cabozantinib, a tyrosine kinase inhibitor that works by blocking cancer cell growth and preventing the formation of blood vessels that supply tumors.
As a registered pharmacist from India, I ensure the supply of genuine Cabozer 40 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Cabozer 40 mg (Cabozantinib)?Cabozer 40 mg contains Cabozantinib 40 mg, which is commonly prescribed for:
Renal Cell Carcinoma (Kidney Cancer)
Hepatocellular Carcinoma (Liver Cancer)
Medullary Thyroid Cancer
It is a targeted therapy designed to control cancer progression and improve patient outcomes.
Cabozantinib 40 mg UsesKey uses of Cabozantinib 40 mg tablets include:
Inhibiting tumor growth
Blocking angiogenesis (blood vessel formation in tumors)
Slowing the spread of cancer cells
Supporting long-term cancer management
Cabozantinib belongs to the class of tyrosine kinase inhibitors (TKIs). It works by:
Blocking specific enzymes that promote cancer growth
Preventing tumor blood supply
Reducing tumor size and progression
Take Cabozer 40 mg tablets exactly as prescribed by a healthcare professional
Usually taken once daily on an empty stomach
Swallow whole with water; do not crush or chew
Cabozantinib tablets are available in multiple strengths for flexible treatment:
20 mg
40 mg
60 mg
As a registered pharmacist and pharmaceutical exporter from India, we provide:
Genuine and quality-assured oncology medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable global shipping
Complete export documentation
Professional customer support
Cabozer 40 mg (Cabozantinib Tablets 40 mg) is a trusted and effective targeted therapy for treating various advanced cancers. With assured quality, expert handling, and reliable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 2000 / Bottle Get Latest Price
| Strength | 60 mg |
| Brand | Cabozer |
| Tablets per Pack | 30 Tablets |
| Usage | Renal Cancer, Thyroid Cancer, Cancer Care, Liver Cancer |
| Form | Tablet |
| Pack Type | Bottle |
Cabozer 60 mg Cabozantinib Tablets 60 mg is a highly effective targeted anti-cancer medication used in the treatment of advanced cancers, including kidney, liver, and thyroid cancers. It contains Cabozantinib, a potent tyrosine kinase inhibitor that helps slow tumor growth and block the blood supply required for cancer progression.
As a registered pharmacist from India, I ensure the supply of genuine Cabozer 60 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Cabozer 60 mg (Cabozantinib)?Cabozer 60 mg contains Cabozantinib 60 mg, which is commonly prescribed for:
Renal Cell Carcinoma (Kidney Cancer)
Hepatocellular Carcinoma (Liver Cancer)
Medullary Thyroid Cancer
It is a targeted therapy designed to control cancer progression and improve patient outcomes.
Cabozantinib 60 mg UsesKey uses of Cabozantinib 60 mg tablets include:
Slowing the growth and spread of cancer cells
Blocking tumor blood vessel formation (anti-angiogenesis)
Supporting long-term disease management
Improving progression-free survival
Cabozantinib belongs to the class of tyrosine kinase inhibitors (TKIs). It works by:
Inhibiting enzymes responsible for tumor growth
Preventing blood supply to tumors
Reducing cancer cell proliferation
Take Cabozer 60 mg tablets exactly as prescribed by a healthcare professional
Usually taken once daily on an empty stomach
Swallow whole with water; do not crush or chew
Cabozantinib tablets are available in multiple strengths for flexible dosing:
20 mg
40 mg
60 mg
As a registered pharmacist and pharmaceutical exporter from India, we provide:
Genuine and quality-assured oncology medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable global shipping
Complete export documentation
Professional customer support
Cabozer 60 mg (Cabozantinib Tablets 60 mg) is a trusted and effective targeted therapy for managing advanced cancers. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 2500 / Box Get Latest Price
| Strength | 25 mg |
| Brand | Eltrombo |
| Pack Size | 28 Tablets |
| Manufacturer | Aprazer |
| Form | Tablet |
| Composition | Eltrombopag Olamine |
| Shelf Life | 36 Months |
| Prescription Type | Prescription |
| Indication | Aplastic Anaemia, ITP, HCV Thrombocytopenia |
Eltrombo 25 mg Eltrombopag Olamine Tablets 25 mg is a clinically proven medication used to treat conditions associated with low platelet counts (thrombocytopenia). It contains Eltrombopag Olamine, a thrombopoietin receptor agonist that helps stimulate platelet production in the bone marrow.
As a registered pharmacist from India, I ensure the supply of genuine Eltrombo 25 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.
What is Eltrombo 25 mg (Eltrombopag Olamine)?Eltrombo 25 mg contains Eltrombopag Olamine 25 mg, which is commonly prescribed for:
Chronic Immune Thrombocytopenia (ITP)
Aplastic Anemia
Thrombocytopenia in patients with chronic hepatitis C
It is used to increase platelet levels and reduce the risk of bleeding.
Eltrombopag 25 mg UsesKey uses of Eltrombopag 25 mg tablets include:
Stimulating platelet production
Reducing bleeding risk
Supporting treatment in chronic blood disorders
Improving overall platelet stability
Eltrombopag Olamine works by:
Activating thrombopoietin receptors in the bone marrow
Increasing platelet production
Helping maintain healthy platelet levels
Take Eltrombo 25 mg tablets exactly as prescribed by a healthcare professional
Usually taken once daily on an empty stomach
Avoid taking with calcium-rich foods or supplements close to dosing
Eltrombopag tablets are available in different strengths:
25 mg
50 mg
75 mg
As a registered pharmacist and pharmaceutical exporter from India, we provide:
Genuine and quality-assured medicines
Competitive pricing for bulk and export orders
Proper storage and handling compliance
Secure packaging and reliable worldwide shipping
Complete export documentation
Professional customer support
Eltrombo 25 mg (Eltrombopag Olamine Tablets 25 mg) is a trusted and effective treatment for managing low platelet counts and related conditions. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.
For pricing, bulk orders, or export inquiries, feel free to contact us.
₹ 20554.5 / Vial Get Latest Price
| Strength | 60 mg |
| Pre Filled Volume | 1 ml |
| Brand | Domvel |
| Packaging Type | PFS |
| Manufacturer | Eris Life Sciences Ltd |
| Indication | Cancer, Osteoporosis, Giant Cell Tumor, Bone Metastasis |
| Composition | Denosumab |
| Route | Subcutaneous |
| Storage Temp | 2–8°C |
Domvel 60 mg PFS Injection
Composition: Denosumab 60 mg / 1 ml Pre-Filled Syringe
International Trade Name: Prolia / Xgeva
Domvel 60 mg PFS is a premium Denosumab injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Denosumab 60 mg in a 1 ml pre-filled syringe, a fully human monoclonal antibody internationally recognized under the brand names Prolia and Xgeva. It is widely used in the treatment of osteoporosis, bone loss associated with cancer therapy, and prevention of skeletal-related events in patients with bone metastases.
Domvel 60 mg injection, Denosumab 60 mg PFS, Prolia generic injection, Xgeva generic injection, Denosumab exporter India, Denosumab bulk supplier, oncology and bone health Denosumab injection, and Denosumab manufacturer India.
Manufactured under stringent GMP standards, Domvel 60 mg PFS ensures consistent quality, precise dosage, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and specialty care markets.
₹ 847.88 / Vial Get Latest Price
| Strength | 50 mg |
| Formulation Type | Liposomal |
| Form Of Medicine | Solution |
| Brand | Adrim |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Storage Condition | Refrigerate (2-8°C) |
| Shelf Life | 36 months |
| Pharmacopoeia Standard | IP |
| Packaging Size | 25 ml |
| Composition | Doxorubicin Hydrochloride |
Adrim 50 mg Injection
Composition: Doxorubicin 50 mg Injection
International Trade Name: Doxorubicin
Adrim 50 mg is a premium Doxorubicin injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Doxorubicin 50 mg, an anthracycline antineoplastic agent widely recognized for its efficacy in treating breast cancer, leukemia, lymphoma, sarcomas, and other solid tumors.
Adrim 50 mg injection, Doxorubicin 50 mg injection, Doxorubicin generic injection, Doxorubicin exporter India, Doxorubicin bulk supplier, oncology Doxorubicin injection, and Doxorubicin manufacturer India.
Manufactured under stringent GMP standards, Adrim 50 mg ensures consistent quality, accurate concentration, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.
₹ 41994 / Vial Get Latest Price
| Strength | 400 mg |
| Volume | 16 ml |
| Pharmaceutical Form | Solution for Infusion |
| Brand | Dr Reddy's Laboratories Ltd |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Shelf Life | 36 months |
| Country Of Origin | India |
| Product Type | Branded Biosimilar |
| Active Ingredient | Bevacizumab |
Versavo 400 Solution for Infusion
Composition: Bevacizumab Solution for Infusion 400mg
International Trade Name: Avastin®
Versavo 400 is a high-quality Bevacizumab 400mg Solution for Infusion, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Versavo 400 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.
Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and reducing blood supply to cancer cells. Versavo 400 Solution for Infusion is indicated for the treatment of multiple malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens as per clinical guidelines.
High-ranking search keywords include: Bevacizumab 400mg infusion, Versavo 400 infusion, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.
Versavo 400 Bevacizumab Solution for Infusion is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The infusion is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.
₹ 29990.00 / Vial Get Latest Price
| Strength | 420 mg |
| Pack Size | 14 ml |
| Brand | Perzea |
| Manufacturer | Hetero Drugs |
| Route of Administration | Intravenous |
| Dosage Form | Injection |
| Formulation Type | Solution Concentrate |
| Shelf Life | 36 months |
| Storage Condition | 2-8 degree c |
| Composition | Pertuzumab |
Perzea 420mg Injection
Composition: Pertuzumab Injection 420mg
International Trade Name: Perjeta®
Perzea 420 is a high-quality Pertuzumab 420mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Perjeta®. Manufactured in WHO-GMP certified facilities following stringent biologics manufacturing standards, Perzea 420 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.
Pertuzumab is a humanized monoclonal antibody that targets the HER2 receptor, specifically inhibiting HER2 dimerization with other HER family receptors. This dual HER2 blockade mechanism significantly reduces tumor cell proliferation and survival. Perzea 420 Injection is primarily indicated for the treatment of HER2-positive breast cancer, including metastatic breast cancer and early-stage breast cancer, in combination with trastuzumab and chemotherapy as per established treatment protocols.
High-ranking search keywords include: Pertuzumab 420mg injection, Perzea 420 injection, Perjeta biosimilar, pertuzumab price, HER2 positive breast cancer treatment, pertuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.
Perzea 420 Pertuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, clinical efficacy, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.
₹ 6360 / Box Get Latest Price
| Strength | 100 mcg |
| Brand | Darberel |
| Dose Form | Vial |
| Molecule | Darbepoetin Alfa |
| Indication | Chemotherapy Anaemia |
| Pack Size | Single PFS |
| Route | SC |
| Storage | 2–8°C |
Darberel 100 mcg PFS Injection
Composition: Darbepoetin Alfa Injection 100 mcg/0.5 ml (Pre-Filled Syringe)
International Trade Name: Aranesp®
Darberel 100 mcg PFS is a high-quality Darbepoetin Alfa 100 mcg Injection, a biosimilar/generic equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Darberel 100 mcg Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.
Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Darberel 100 mcg PFS Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions when used according to clinical guidelines.
High-ranking search keywords include: Darbepoetin alfa 100 mcg injection, Darberel 100 mcg PFS, Aranesp biosimilar, darbepoetin price, anemia treatment injection, CKD anemia therapy, darbepoetin exporter India, and erythropoiesis stimulating agent supplier.
Darberel 100 mcg Darbepoetin Alfa Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The pre-filled syringe (0.5 ml) format allows accurate dosing and ease of administration. The product is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for dialysis centers, oncology hospitals, government supply programs, specialty distributors, and international pharmaceutical procurement channels.
₹ 11506.5 / Vial Get Latest Price
| Formulation Type | Nanoparticle Albumin-Bound |
| Brand | Z Taxel |
| Pharmacopoeia Standard | IP |
| Strength | 300 mg |
| Packaging Size | 50 ml |
| Shelf Life | 36 months |
| Storage Temperature | 2-8 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
Z-Taxel 300mg Injection
Composition: Paclitaxel Injection 300mg
International Trade Name: Taxol®
Z-Taxel 300 is a high-quality Paclitaxel 300mg Injection, a generic equivalent of the internationally recognized taxane-class chemotherapeutic agent marketed under the brand name Taxol®. Manufactured in WHO-GMP certified facilities, Z-Taxel 300 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.
Paclitaxel is an antimicrotubule antineoplastic agent that promotes microtubule assembly and stabilizes them against depolymerization, thereby inhibiting normal microtubule dynamics required for cell division. Z-Taxel 300 Injection is primarily indicated for the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), Kaposi’s sarcoma, and other solid tumors, either as monotherapy or in combination with other chemotherapeutic agents as per established protocols.
High-ranking search keywords include: Paclitaxel 300mg injection, Z-Taxel 300 injection, Taxol generic, paclitaxel price, taxane chemotherapy, oncology injectable exporter India, paclitaxel supplier, and anticancer injection manufacturer India.
Z-Taxel 300 Paclitaxel Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer treatment centers, government supply programs, and international pharmaceutical distributors.
₹ 60 / Strip Get Latest Price
| Strength | 8 mg |
| Brand | Dexcin |
| Form | Tablet |
| Packaging Size | 8.0 tablets in 1 strip |
| Usage | Arthritis, Cancer Therapy, Allergy, Asthma, COVID Related, Other Inflammatory |
| Packaging Type | Strip |
| Manufacturer | GLS Pharma Ltd. |
Decmax Dexamethasone 8mg Tablet
Composition: Dexamethasone Tablets 8mg
International Trade Names: Decadron® / Ozurdex® / Dexycu®
Decmax is a high-quality Dexamethasone 8mg Tablet, a generic equivalent of the internationally recognized corticosteroid marketed under well-known brand names such as Decadron®, Ozurdex®, and Dexycu® (different formulations and indications). Manufactured in WHO-GMP certified facilities, Decmax Tablets are supplied by trusted pharmaceutical exporters from India to support global hospital, oncology, immunology, and specialty care treatment programs.
Dexamethasone is a potent synthetic glucocorticoid with strong anti-inflammatory, immunosuppressive, and anti-edema properties. Decmax 8mg Tablets are widely indicated for the management of inflammatory and autoimmune disorders, allergic reactions, cerebral edema, hematological malignancies, and as a supportive medication in oncology for chemotherapy-induced nausea, hypersensitivity prevention, and tumor-related inflammation.
High-ranking search keywords include: Dexamethasone 8mg tablet, Decmax tablet, Decadron generic tablet, dexamethasone price, corticosteroid tablet, anti-inflammatory steroid, oncology supportive care drug, dexamethasone exporter India, and GMP steroid tablet manufacturer.
Decmax Dexamethasone 8mg Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospitals, oncology centers, intensive care units, specialty clinics, government supply programs, and international pharmaceutical distributors.
₹ 4750.00 / Vial Get Latest Price
| Strength | 2mg |
| Formulation Type | Liposomal |
| Form Of Medicine | Powder |
| Brand | Doxorex |
| Manufacturer | SAMARTH LIFE SCIENCES PVT LTD |
| Storage Condition | Refrigerate (2-8°C) |
| Shelf Life | 36 months |
| Pharmacopoeia Standard | IP |
| Packaging Size | 2 ml |
| Composition | Doxorubicin Hydrochloride |
Doxorex PL 2mg is a high-quality Liposomal Doxorubicin 2mg Injection, a generic equivalent of the internationally recognized pegylated liposomal anthracycline formulation marketed under the brand name Doxil®. Manufactured in WHO-GMP certified facilities using advanced liposomal drug delivery technology, Doxorex PL Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.
Liposomal doxorubicin is an encapsulated formulation of doxorubicin designed to enhance tumor targeting while reducing systemic toxicity. The liposomal delivery system prolongs circulation time and lowers cardiotoxicity compared to conventional doxorubicin. Doxorex PL 2mg Injection is primarily indicated for the treatment of ovarian cancer, multiple myeloma, Kaposi’s sarcoma, and breast cancer in specific clinical settings.
High-ranking search keywords include: Liposomal doxorubicin 2mg injection, Doxorex PL injection, Doxil generic, pegylated liposomal doxorubicin price, anthracycline chemotherapy, oncology injectable exporter India, and liposomal anticancer drug manufacturer India.
Doxorex PL 2mg Liposomal Doxorubicin Injection is manufactured under strict GMP quality standards, ensuring liposome integrity, consistent drug encapsulation, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer institutes, government supply programs, and international pharmaceutical distributors.
₹ 245.7 / Vial Get Latest Price
| Strength | 50 mg |
| Formulation Type | Liposomal |
| Form Of Medicine | Solution |
| Brand | Doxorex |
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Storage Condition | Refrigerate (2-8°C) |
| Shelf Life | 36 months |
| Pharmacopoeia Standard | IP |
| Packaging Size | 25 ml |
| Composition | Doxorubicin Hydrochloride |
Doxorex 50mg Injection
Composition: Doxorubicin Hydrochloride Injection 50mg
International Trade Name: Adriamycin®
Doxorex 50 is a high-quality Doxorubicin 50mg Injection, a generic equivalent of the internationally recognized anthracycline antineoplastic agent marketed under the brand name Adriamycin®. Manufactured in WHO-GMP certified facilities, Doxorex 50 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology treatment programs.
Doxorubicin is an anthracycline antibiotic that intercalates DNA, inhibits topoisomerase II, and generates free radicals, leading to inhibition of DNA replication and apoptosis of rapidly dividing cancer cells. Doxorex 50mg Injection is widely indicated for the treatment of breast cancer, lymphomas, leukemias, sarcomas, ovarian cancer, and various other solid tumors, either as monotherapy or in combination chemotherapy regimens.
High-ranking search keywords include: Doxorubicin 50mg injection, Doxorex 50 injection, Adriamycin generic, doxorubicin price, anthracycline chemotherapy, oncology injectable exporter India, and anticancer injection manufacturer India.
Doxorex 50 Doxorubicin Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer treatment centers, government supply programs, and international pharmaceutical distributors.
₹ 11838 / Vial Get Latest Price
| Strength | 100 mg |
| Volume | 1.0 Solution for Infusion in 1 vial |
| Pharmaceutical Form | Lyophilized Powder |
| Brand | Bevatas |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Shelf Life | 36 months |
| Country Of Origin | India |
| Product Type | Branded Biosimilar |
| Active Ingredient | Bevacizumab |
| Manufacturer | Hetero Drugs Ltd |
Cizumab 100mg Injection
Composition: Bevacizumab Injection 100mg
International Trade Name: Avastin®
Cizumab 100 is a high-quality Bevacizumab 100mg Injection, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Cizumab 100 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.
Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and reducing blood supply to cancer cells. Cizumab 100mg Injection is indicated for the treatment of multiple malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens as per clinical guidelines.
High-ranking search keywords include: Bevacizumab 100mg injection, Cizumab 100 injection, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.
Cizumab 100 Bevacizumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.
Hansaben Kantilal Patel (CEO)
Shivanta Impex
Shop No 04, Shri Ram Kunj, Central Avenue
Bagadganj, Nagpur - 440008, Maharashtra, India